Pfizer wins bidding war for Metsera and its weight-loss drugs
By 
Phillip Broadwith2025-11-11T08:41:00
US firm matched Novo Nordisk’s rival bid and had backing of competition regulator
Metsera, the US biotech with a pipeline of next-generation metabolic hormone weight loss drugs, has agreed a sale to Pfizer following a bidding war between the US pharma giant and Novo Nordisk.